QQ客服 官方微博 反馈留言

	Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival
	An, Gang; Wang, Huijun; Qin, Xiaoqi; Shi, Lihui; Xu, Yan; Deng, Shuhui; Sui, Weiwei; Zhu, Guoqing; Yao, Hongjing; Yi, Shuhua
	2014
卷号	38期号:6页码:666-672
关键词	Multiple myeloma Polyclonal IgM Residual normal plasma cells MGUS-like
ISSN号	0145-2126
DOI	10.1016/j.leukres.2014.02.009
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6683519
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	An, Gang,Wang, Huijun,Qin, Xiaoqi,et al. Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival[J],2014,38(6):666-672.
APA	An, Gang.,Wang, Huijun.,Qin, Xiaoqi.,Shi, Lihui.,Xu, Yan.,...&Qiu, Lugui.(2014).Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival.,38(6),666-672.
MLA	An, Gang,et al."Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival".38.6(2014):666-672.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。